Clincosm LogoSign in Get a demo

Waldenstrom Macroglobulinemia

Showing 26 - 50 of 154
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asymptomatic COVID-19 Infection Laboratory-Confirmed, B-Cell Tumor, Chronic Lymphocytic Leukemia Trial in Rochester (Ibrutinib,

Withdrawn
  • Asymptomatic COVID-19 Infection Laboratory-Confirmed
  • +8 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 2, 2022

Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia Trial in United States (Ibrutinib, Rituximab, Venetoclax)

Suspended
  • Lymphoplasmacytic Lymphoma
  • Waldenstrom Macroglobulinemia
  • Centralia, Illinois
  • +73 more
Jul 27, 2022

Relapsed/Refractory B-cell Lymphomas, Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in United States

Recruiting
  • Relapsed/Refractory B-cell Lymphomas
  • +11 more
  • CLBR001 and SWI019
  • Duarte, California
  • +7 more
Jul 26, 2022

B-cell Malignancy, Low-grade, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma Trial in China (BGB-16673)

Recruiting
  • B-cell Malignancy, Low-grade
  • +4 more
  • Beijing, Beijing, China
  • +8 more
Jul 20, 2022

Spanish Registry of Patients With IgM Monoclonal Gammopathies

Recruiting
  • Waldenstrom Macroglobulinemia
    • Mieres, Asturias, Spain
    • +24 more
    Jul 5, 2022

    MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Atlanta, Columbus (drug, biological,

    Completed
    • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
    • +8 more
    • PI3K inhibitor BKM120
    • +3 more
    • Atlanta, Georgia
    • +1 more
    Jun 27, 2022

    MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,

    Active, not recruiting
    • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
    • +9 more
    • BTK inhibitor PCI-32765
    • +5 more
    • Columbus, Ohio
      Ohio State University Medical Center
    Jun 27, 2022

    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

    Completed
    Has Results
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +20 more
    • Scottsdale, Arizona
    • +1 more
    May 6, 2022

    CLL/SLL, Waldenstrom Macroglobulinemia, Follicular Lymphoma Trial in Cincinnati, Columbus, Salt Lake City (LP-168)

    Recruiting
    • CLL/SLL
    • +6 more
    • Cincinnati, Ohio
    • +2 more
    May 7, 2022

    Non Hodgkin Lymphoma, Follicular Lymphoma, Indolent Lymphoma Trial in Miami, Baltimore, Milwaukee (Zydelig)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • +8 more
    • Miami, Florida
    • +2 more
    Apr 21, 2022

    MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance (MGUS)
    • +8 more
      • Boston, Massachusetts
      • +6 more
      Apr 14, 2022

      Waldenstrom Macroglobulinemia Trial in Hackensack (Carfilzomib, Rituximab, Dexamethasone)

      Completed
      Has Results
      • Waldenstrom Macroglobulinemia
      • Hackensack, New Jersey
        John Theurer Cancer Center at Hackensack University Medical Cent
      Mar 18, 2022

      Waldenstrom Macroglobulinemia, MYD88 Gene Mutation Trial in Boston (IBRUTINIB, Venetoclax)

      Active, not recruiting
      • Waldenstrom Macroglobulinemia
      • MYD88 Gene Mutation
      • Boston, Massachusetts
      • +1 more
      Apr 1, 2022

      Waldenstrom Macroglobulinemia Trial in Austria, Germany, Greece (Carfilzomib + Ibrutinib, Ibrutinib)

      Recruiting
      • Waldenstrom Macroglobulinemia
      • Salzburg, Austria
      • +16 more
      Mar 11, 2022

      Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia Trial in Australia,

      Recruiting
      • Follicular Lymphoma
      • +7 more
      • Louisville, Kentucky
      • +4 more
      Mar 11, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

      Enrolling by invitation
      • Chronic Lymphocytic Leukemia
      • +6 more
      • Duarte, California
      • +165 more
      Mar 24, 2022

      Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)

      Recruiting
      • Waldenstrom Macroglobulinemia
      • DASATINIB
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Mar 22, 2022

      Waldenstrom Macroglobulinemia Trial in Boston (Loncastuximab Tesirine, Dexamethasone)

      Recruiting
      • Waldenstrom Macroglobulinemia
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Mar 1, 2022

      CLL/SLL, NHL, MCL Trial in United States (HMPL-760)

      Recruiting
      • CLL/SLL
      • +8 more
      • Atlanta, Georgia
      • +3 more
      Feb 24, 2022

      Waldenstrom Macroglobulinemia Trial in Germany, Greece (Ibrutinib / Bortezomib / Rituximab)

      Active, not recruiting
      • Waldenstrom Macroglobulinemia
      • Ibrutinib / Bortezomib / Rituximab
      • Berlin, Germany
      • +14 more
      Mar 7, 2022

      Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia
      • +125 more
      • tetanus-CMV fusion peptide vaccine
      • laboratory biomarker analysis
      • Duarte, California
        City of Hope Medical Center
      Feb 28, 2022

      Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Trial in Australia, United States (NKX019)

      Recruiting
      • Lymphoma, Non-Hodgkin
      • +9 more
      • NKX019
      • Denver, Colorado
      • +6 more
      Jan 19, 2022

      Waldenstrom Macroglobulinemia, Waldenstrom's Disease, Waldenström; Hypergammaglobulinemia Trial in New York (Ibrutinib,

      Recruiting
      • Waldenstrom Macroglobulinemia
      • +6 more
      • New York, New York
        Weill Cornell Medicine
      Dec 21, 2021

      Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in United States (oprozomib)

      Terminated
      • Multiple Myeloma
      • Waldenstrom Macroglobulinemia
      • Scottsdale, Arizona
      • +18 more
      Nov 15, 2021

      IgA Monoclonal Gammopathy, IgG Monoclonal Gammopathy, IgM Monoclonal Gammopathy Trial in Atlanta (Rifaximin)

      Recruiting
      • IgA Monoclonal Gammopathy
      • +8 more
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Oct 18, 2021